Balance
1
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
TakedaRamelteon
UNION therapeuticsStress
Design Therapeuticsexperimental foot device
Clinical Trials (3)
Total enrollment: 350 patients across 3 trials
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
Start: Jul 2005Est. completion: Oct 2006275 patients
Phase 3Completed
Detection of Balance in the Elderly Under the Influence of Stress
Start: Nov 2024Est. completion: Jul 202660 patients
N/ARecruiting
Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking
Start: Oct 2018Est. completion: Mar 201915 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 350 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.